Estimate Recalculated Nov 11, 2024 01:40PM EST
S. Edward Torres does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Receptos, Inc., Protagonist Therapeutics, Inc, Surface Oncology, Inc., Aeglea BioTherapeutics, Inc., AILERON THERAPEUTICS INC, and GLOBEIMMUNE INC.
S. Edward Torres's CIK is 0001552293
2015 was S. Edward Torres's most active year for acquiring shares with 2 total transactions. S. Edward Torres's most active month to acquire stocks was the month of June. 2015 was S. Edward Torres's most active year for disposing of shares, totalling 3 transactions. S. Edward Torres's most active month to dispose stocks was the month of July. 2013 saw S. Edward Torres paying a total of $0.00 for 18,800 shares, this is the most they've acquired in one year. In 2015 S. Edward Torres cashed out on 35,600 shares for a total of $5,931,588.00, their largest year based on trade value.
Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!